Hematology and Oncology
Home Hematology and Oncology
FDA: Opdivo Approval Expanded to Include Lung Cancer
FDA approves drug for NSCLC patients who have been treated with platinum-based chemotherapy
Research Measures Perceptions of Physician Compassion
Patients perceive higher level of compassion among physicians who provide a more optimistic message
February 2015 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for February 2015. This roundup includes...
L858R Mutation in Circulating Free DNA Is Prognostic in NSCLC
L858R mutation in tumor tissue or cfDNA is marker of shorter overall, progression-free survival
Hospital Design Has Little Effect on Patient Satisfaction
Aesthetics aren't as important as care from doctors, nurses, and staff, researchers note
Genitourinary Cancers Symposium, Feb. 26-28
The 2015 Genitourinary Cancers Symposium The American Society of Clinical Oncology's annual Genitourinary Cancers Symposium was held from Feb. 26 to 28 in...
Genetic Mutations Found in Leukemia Rise With Age
But just having cancer-linked DNA doesn't mean the disease will develop, study authors stress
AMA: Key Steps for Minimizing Liability Risk in Telemedicine
Include defining minimum requirement necessary for establishing doctor-patient relationship
Oral Bisphosphonate Use Tied to Lower Endometrial Cancer Risk
Reduction in endometrial cancer risk with ever use in large cohort of postmenopausal women
Researchers Examine Etiology of Ibrutinib Discontinuation in CLL
Poor prognosis after discontinuation for disease progression, especially Richter's transformation
